Pancreas · 2020 · 20 citations · 21 references
MedicineOncologySurgeryCancer EpidemiologyGastrointestinal OncologySurgical OncologyCancer DisparitiesCancer Health DisparitiesCancer Survival AnalysisEthnic MinoritiesNeuroendocrine Tumor TherapyPancreatic CancerCancer Epidemiology By EthnicityCancer Epidemiology By RaceCox RegressionEthnic Cancer DisparitiesGastrointestinal Neuroendocrine TumorsRacial Cancer DisparitiesRacial Disparities Over TimeRacial Risk Disparities
OBJECTIVES: The objective of this study was to evaluate racial differences in cancer treatment and survival in gastroenteropancreatic neuroendocrine tumor (GEP-NET) patients. METHODS: Using the Surveillance, Epidemiology, and End Results Registry, we identified patients with GEP-NETs of the stomach, small intestine (SI), colon, rectum, appendix, and pancreas diagnosed between 1973 and 2014. Demographic, cancer, and treatment information were collected and compared using χ2 tests. Multivariable logistic and Cox regression were used to determine disparities in receiving treatment and overall survival. RESULTS: We identified 19,031 GEP-NET patients: 2839 were non-Hispanic Blacks, 12,832 non-Hispanic Whites, 2098 Hispanics, and 1262 Asians. African Americans and Hispanics with SI and pancreatic NETs were less likely to be treated with surgery (odds ratio, 0.6; 95% confidence interval [CI], 0.46-0.69; odds ratio, 0.71; 95% CI, 0.51-0.99, respectively). African American race was not an independent predictor of survival; there was a strong trend in stomach, SI, and pancreas NETs (hazard ratio [HR], 1.31; 95% CI, 1-1.7; HR, 1.2; 95% CI, 0.99-1.45; HR, 1.22; 95% CI, 1-1.48, respectively). CONCLUSIONS: Our study provides evidence of racial disparities in treatment and survival across GEP-NET primary sites and racial groups. Further studies should be performed to improve our understanding of the reason for these disparities.
21
Rebecca L. Siegel, Elizabeth Ward, Otis W. Brawley et al. · CA A Cancer Journal for Clinicians · 2011 · 4.1K citations · Full text
Neuroendocrine tumor epidemiology
Øyvind Hauso, Björn Gustafsson, Mark Kidd et al. · Cancer · 2008 · 511 citations · Full text